Updates on the Latest Clinical Trials that Have Changed Our Disease Management

ESGO eAcademy, Faculty / Presenters, 4193868

Grand Rounds 3: Vulvar Cancer

ESGO eAcademy, Faculty / Presenters, 4193866

Transforming ovarian cancer diagnostic pathways (SONATA): ROMA versus CA125 in community setting for diagnosis of ovarian and uterine cancer, real-world prospective diagnostic test accuracy study: preliminary analysis of secondary outcome

ESGO eAcademy, Sudha Sundar, 4193646

Best Three Minutes Presentations

ESGO eAcademy, Faculty / Presenters, 4193867

Hall D2 27-feb

ESGO eAcademy, Faculty / Presenters, 4193382

Q&A and Closing Remarks

ESGO eAcademy, Domenica Lorusso, 4193638

Discussion

ESGO eAcademy, Faculty / Presenters, 4193626

Living with Advanced Ovarian Cancer

ESGO eAcademy, Robin Gooch, 4193637

Living with Advanced Ovarian Cancer

ESGO eAcademy, Jalid Sehouli, 4193636

Currently Recruiting Trials in Gynaecological Cancers

ESGO eAcademy, David Tan, 4193625

PARP Inhibitors: Unveiling Their Role in HRD-Negative and HRD-Unknown patients

ESGO eAcademy, Vanda Salutari, 4193635

Development of HER2 Guided Therapies in Gynaecological Cancers

ESGO eAcademy, Alexandra Leary, 4193624

Sustaining the Future: Long-Term Insights on First-Line Maintenance in Advanced Ovarian Cancer

ESGO eAcademy, Rebecca Kristeleit, 4193634

HER2-Directed Therapies and Biomarker Testing in Gynaecological Cancers

ESGO eAcademy, Faculty / Presenters, 4193863

Shaping the Future of Endometrial Cancer Management: Clinical Strategies and Study Updates

ESGO eAcademy, Faculty / Presenters, 4193864

PARP Inhibitors in Advanced Ovarian Cancer. Expanding Horizons: Transforming Outcomes and Supporting Patients to Move Forward

ESGO eAcademy, Faculty / Presenters, 4193865

HER2 Testing as Biomarker

ESGO eAcademy, Xavier Matias-Guiu, 4193623

Introduction

ESGO eAcademy, Domenica Lorusso, 4193633

Discussion

ESGO eAcademy, Faculty / Presenters, 4193615

Discussion

ESGO eAcademy, Nicole Concin, 4193611

Rare Ovarian Tumours in Pregnancy. A Multidisciplinary Approach to Complex Cases

ESGO eAcademy, Joanna Kacperczyk-Bartnik, 4193614

AUD 10-11-12 27-feb

ESGO eAcademy, Faculty / Presenters, 4193385

CON

ESGO eAcademy, Nadeem R. Abu-Rustum, 4193610

Managing Clear Cell Carcinomas of the Cervix and Endometrium

ESGO eAcademy, David Tan, 4193613

Management of Rare Tumours

ESGO eAcademy, Faculty / Presenters, 4193861

PRO

ESGO eAcademy, Aditi Bhatt, 4193609

Precision Medicine in Rare Uterine Malignancies: Endometrial Stromal Sarcoma

ESGO eAcademy, Isabelle Ray-Coquard, 4193612

Is Selective Peritonectomy Equally Good Compared to Total Peritonectomy?

ESGO eAcademy, Faculty / Presenters, 4193860

Live Surgery Transmission

ESGO eAcademy, Henrik Falconer, 4193586

Endometrial Cancer Mobile App Update 2025

ESGO eAcademy, Enora Laas, 4193600

Survivorship clinic for long-term survivors of gynecological cancer: first multicenter interventional trial evaluating a novel systematic gynecological cancer survivorship program

ESGO eAcademy, Hannah Woopen, 4193594

The mechanism of apatinib reprogramming arginine metabolism in cervical cancer to enhance the anti-tumor effect of anti-PD-1 immunotherapy

ESGO eAcademy, Lin Zhou, 4193593

Updated survival analysis of cadonilimab (AK104) monotherapy in recurrent or metastatic cervical cancer: focus on complete responders

ESGO eAcademy, Xiaohua Wu, 4193592

The Old and the New Found: ER and PR Receptor

ESGO eAcademy, Nicole Concin, 4193598

Predicting lymph node metastasis in operable cervical cancer: external validation of a preoperative model to identify patients at risk for dual surgical and radiotherapeutic treatment

ESGO eAcademy, Nuria Agusti Garcia, 4193591

Urine and vaginal self-sampling to encourage participation in cervical screening in current non-attenders.

ESGO eAcademy, Jiexin Cao, 4193589

Low-Grade Endomerioid Carcinoma of Both, the Endometrium and the Ovary

ESGO eAcademy, Xavier Matias-Guiu, 4193597

Opportunistic cytology versus self-sampling - the future of cervical cancer screening in poland

ESGO eAcademy, Krzysztof Nowosielski, 4193588

Tumour Biology beyond Molecular Classification: The Role of LVSI

ESGO eAcademy, Ilaria Capasso, 4193596

HPV-related cancers and second primary events in the E3N french prospective cohort

ESGO eAcademy, Laurane Edorh, 4193587

Mini Oral Session 2: Cervical Cancer

ESGO eAcademy, Faculty / Presenters, 4193856

GO–digital: prompt-based information extraction from gynecologic oncology reports using llms and a clinical decision-support dashboard

ESGO eAcademy, Chiara Cantarini, 4193590

ESGO-ESTRO-ESP Guidelines on Endometrial Cancer and FIGO Staging in Light of Molecular Classification and Tumour Biology

ESGO eAcademy, Faculty / Presenters, 4193857

Live Surgery Transmission

ESGO eAcademy, Faculty / Presenters, 4193855

Copenhagen Drummers

ESGO eAcademy, Faculty / Presenters, 4193580

IJGC Awards

ESGO eAcademy, Pedro Ramirez, 4193578

Welcome Address

ESGO eAcademy, Viola Heinzelmann, 4193576

Welcome Address

ESGO eAcademy, Anna Fagotti, 4193575

Welcome Address

ESGO eAcademy, Mansoor Raza Mirza, 4193577

Opening Ceremony

ESGO eAcademy, Faculty / Presenters, 4193853

Discussion

ESGO eAcademy, Faculty / Presenters, 4193574

Discussion

ESGO eAcademy, Faculty / Presenters, 4193566

Molecular Image-Guided Surgery in the Era of Precision Oncology

ESGO eAcademy, Angela Collarino, 4193573

What Not to Do in Case of Complications

ESGO eAcademy, Houssein El Hajj, 4193569

Patients' Quality of Life

ESGO eAcademy, Jalid Sehouli, 4193565

Novel agents / side effects

ESGO eAcademy, Shibani Nicum, 4193564

The Impact of Complications on the Surgeon’s Life

ESGO eAcademy, Basel Refky, 4193568

Current and Future Biomarkers in Gyn Cancer

ESGO eAcademy, Iain Mcneish, 4193572

PARPi Resistance - How to Treat

ESGO eAcademy, Jonathan Ledermann, 4193563

Maintenance Therapy in First-line - What Are the Unmet Needs

ESGO eAcademy, Isabelle Ray-Coquard, 4193562

Introduction

ESGO eAcademy, Shibani Nicum, 4193561

Profiles of Surgical Complications in Gynaecological Oncology

ESGO eAcademy, Christina Fotopoulou, 4193567

Grand Rounds 2: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193850

Introduction into Precision Oncology - What Are the Gaps?

ESGO eAcademy, Anniina Färkkilä, 4193571

Complications & Symptom Support in Gynaecological Oncology: Profiles, Pitfalls, and Perspectives

ESGO eAcademy, Faculty / Presenters, 4193851

Biomarkers and Personalised Surgery as Advancements in Precision Oncology

ESGO eAcademy, Faculty / Presenters, 4193852

Hybrid versus technetium-99m tracers for sentinel lymph node mapping in early-stage vulvar cancer: a retrospective single-centre cohort study

ESGO eAcademy, Cristina Celada Castro, 4193560

The RECOVER study: preoperative frailty as a predictor of surgical-site complications after vulvectomy - A retrospective cohort of 761 patients

ESGO eAcademy, Simona Maria Fragomeni, 4193559

Pelvic exenteration for vulvar cancer: survival and morbidity outcomes from the COREPEX (complications and recurrence after pelvic exenteration) project

ESGO eAcademy, Diana Zach, 4193558

Discussion

ESGO eAcademy, Philipp Harter, 4193548

Surgery in the (Very) Obese Patient Population

ESGO eAcademy, Michael Halaska, 4193551

Long-term follow-up of the groningen international studies on sentinel nodes in vulvar cancer (GROINSS-V I & II): outcomes for patients with sentinel node metastases

ESGO eAcademy, Willemijn van der Kolk, 4193557

Side Effects

ESGO eAcademy, Basel Refky, 4193547

Molecular biomarkers in prognosis, prediction and treatment of vulvar cancer: an umbrella review of one of the rarest gynecological cancers

ESGO eAcademy, Rita Trozzi, 4193556

Impact of Surgery - Primary and Secondary Debulking

ESGO eAcademy, Philipp Harter, 4193546

Surgery in the Old and Frail Population

ESGO eAcademy, Frederic Amant, 4193550

ROSELLA (GOG3073, engotov72, APGOT-OV10): a phase 3 study of relacorilant + nab-paclitaxel in patients with platinum-resistant ovarian cancer

ESGO eAcademy, Domenica Lorusso, 4193555

Predictive Markers for the Choice of Systemic Therapy

ESGO eAcademy, Iain Mcneish, 4193545

Assessment of the prevalence and clinical relevance of homologous recombination deficiency in molecularly and clinicopathologically characterized endometrial cancer patients: an austrian multicentre cohort study

ESGO eAcademy, Magdalena Postl, 4193554

Patient Story

ESGO eAcademy, Lise Dons, 4193544

Introduction

ESGO eAcademy, Trine Jakobi Nøttrup, 4193543

Pushing the Boundaries

ESGO eAcademy, Faculty / Presenters, 4193848

Mini Oral Session 1: Miscellaneous

ESGO eAcademy, Faculty / Presenters, 4193849

Grand Rounds 1: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193847

Microscopic assessment of lymph node status in gynecological malignancies using full-field optical coherence tomography

ESGO eAcademy, Matteo Pavone, 4193553

Vaginal Cancer: Breakthroughs, Challenges, and Future Directions - A 20-Year Journey

ESGO eAcademy, Olga P. Matylevich, 4193549

Discussion

ESGO eAcademy, Faculty / Presenters, 4193542

Discussion

ESGO eAcademy, Faculty / Presenters, 4193538

Integrating minimally-invasive surgery and vulvoperineal access in exenterative surgery for recurrent vulval cancer: a video presentation

ESGO eAcademy, Alfonso Altieri, 4193534

Radiotherapy for Oligometastatic Ovarian Cancer Recurrence

ESGO eAcademy, Viola Heinzelmann, 4193541

Video endoscopic inguinal lymphadenectomy in vulvar cancer: step-by-step surgical technique

ESGO eAcademy, María Espías Alonso, 4193533

NO, We Just Need the Immune Checkpoint Inhibitor during Maintenance!

ESGO eAcademy, Christian Marth, 4193537

Robotic assisted groin dissection by lateral approach

ESGO eAcademy, Monika Meena, 4193532

YES, We Need Both the PARP Inhibitor and the Immune Checkpoint Inhibitor during Maintenance!

ESGO eAcademy, Nicoletta Colombo, 4193536

Surgery for Oligometastatic Ovarian Cancer Recurrence

ESGO eAcademy, Christina Fotopoulou, 4193540

Excision of an inguinal lymphadenopaty: surgical steps and tips and tricks to prevent lymphocele and lymphedema

ESGO eAcademy, Ana Luzarraga, 4193531

Case Presentation

ESGO eAcademy, David Viveros Carreno, 4193539

Should PARPi Be Included in the Treatment Options for pMMR Advanced/Recurrent Endometrial Cancer

ESGO eAcademy, Faculty / Presenters, 4193845

Setting the Scene in pMMR Advanced/Recurrent Endometrial Cancer

ESGO eAcademy, Toon Van Gorp, 4193535

Management of Oligometastatic Recurrent Disease in Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193846